Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Supermeres, a new functional extracellular nanoparticle replete with disease biomarkers and therapeutic targets

ABSTRACT: Supermeres, a new functional extracellular nanoparticle replete with disease biomarkers and therapeutic targets

PROVIDER: PRJNA707335 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR13873943.fastq.gz	Fastqsanger.gz
	SRR13873944.fastq.gz	Fastqsanger.gz
	SRR13873945.fastq.gz	Fastqsanger.gz
	SRR13873946.fastq.gz	Fastqsanger.gz
	SRR13873947.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 12

Similar Datasets

Supermeres, a new functional extracellular nanoparticle replete with disease biomarkers and therapeutic target

Project description:Extracellular vesicles, including exosomes, and exomere nanoparticles, are under intense investigation for cargo that may serve as clinical biomarkers or therapeutic targets. Here, we report discovery of a new extracellular nanoparticle, termed supermeres. We performed LC/MS-MS proteomics analyses on gradient-purified sEVs, NVs, exomeres and supermeres. The proteomic profile of supermeres is clearly distinct from that of sEVs, NVs and exomeres This study identifies a new functional nanoparticle replete with potential circulating biomarkers and therapeutic targets that can be exploited for clinical benefit in a host of diseases.

2021-11-02 | PXD025213 | Pride

Supermeres, a new functional extracellular nanoparticle replete with disease biomarkers and therapeutic targets

Project description:Supermeres, a new functional extracellular nanoparticle replete with disease biomarkers and therapeutic targets

| PRJNA707327 | ENA

Supermeres, a new functional extracellular nanoparticle replete with disease biomarkers and therapeutic targets

Project description:RNA-Seq of cellular and extracellular samples from DiFi cells. The distribution of extracellular RNA among cells, sEV pellet, exomeres and supermeres is distinct.

2021-10-12 | GSE168416 | GEO

Supermeres in breast and pancreatic cancer cells

Project description:Extracellular vesicles, including exosomes, and exomere nanoparticles, are under intense investigation for cargo that may serve as clinical biomarkers or therapeutic targets. Here, we report discovery of a new extracellular nanoparticle, termed supermeres. We performed LC/MS-MS proteomics analyses on gradient-purified sEVs, NVs, exomeres and supermeres. The proteomic profile of supermeres is clearly distinct from that of sEVs, NVs and exomeres. This study identifies a new functional nanoparticle replete with potential circulating biomarkers and therapeutic targets that can be exploited for clinical benefit in a host of diseases.

2021-12-01 | PXD027258 | Pride

Supermeres, a new functional extracellular nanoparticle replete with disease biomarkers and therapeutic targets

Project description:This SuperSeries is composed of the SubSeries listed below.

2021-10-12 | GSE168418 | GEO

Supermeres are functional extracellular nanoparticles replete with disease biomarkers and therapeutic targets.

Project description:Extracellular vesicles and exomere nanoparticles are under intense investigation as sources of clinically relevant cargo. Here we report the discovery of a distinct extracellular nanoparticle, termed supermere. Supermeres are morphologically distinct from exomeres and display a markedly greater uptake in vivo compared with small extracellular vesicles and exomeres. The protein and RNA composition of supermeres differs from small extracellular vesicles and exomeres. Supermeres are highly enriched with cargo involved in multiple cancers (glycolytic enzymes, TGFBI, miR-1246, MET, GPC1 and AGO2), Alzheimer's disease (APP) and cardiovascular disease (ACE2, ACE and PCSK9). The majority of extracellular RNA is associated with supermeres rather than small extracellular vesicles and exomeres. Cancer-derived supermeres increase lactate secretion, transfer cetuximab resistance and decrease hepatic lipids and glycogen in vivo. This study identifies a distinct functional nanoparticle replete with potential circulating biomarkers and therapeutic targets for a host of human diseases.

| S-EPMC8656144 | biostudies-literature

Glioblastoma cell supermeres

Project description:To identify small RNAs coming out of glioblastoma cells in supermeres and other carriers

2024-07-31 | GSE272370 | GEO

Glioblastoma cell supermeres

Project description:Glioblastoma cell supermeres

| PRJNA1136530 | ENA

Colorectal cancer cell supermeres

Project description:To identify the best method for isolating supermeres and their small RNA cargo from colorectal cancer cells

2024-07-31 | GSE272487 | GEO

Colorectal cancer cell supermeres isolation methods

Project description:To identify the best method for isolating supermeres and their small RNA cargo from colorectal cancer cells